NK cell as a Novel Tool to Regulate and Inhibit the Progressive Growth of Tumor after Chemotherapy

Munendra Singh Tomar, Sanjay Kumar, Rishi Kant Singh, Praveen Kumar Verma, Surya Pratap Singh, Amit Kumar, Arbind Acharya, Pramod Kumar Gautam and Sanjay Kumar
Additional contact information
Arbind Acharya: Department of Zoology, Banaras Hindu University, India
Pramod Kumar Gautam: Department of Biochemistry, All India Institutes of Medical Sciences, India
Sanjay Kumar: Department of Biological Sciences, Albama State University, USA

Cancer Therapy & Oncology International Journal, 2017, vol. 8, issue 1, 11-13

Abstract: Natural killer Cells (NK cells) are a part of innate immune system that’s play an important role as cytotoxic lymphocytes. Two types of receptors, activating (AR) and inhibitory (IR) are found on NK cells. These receptors have their specific role in the regulation of NK cells for killing the tumor cells or virus infected cells by the stimulation and secretion of cytotoxic granules containing perforin and granzyme. The functions of NK cells are inhibited by regulatory T (Treg) cells through interacting with NK cell surface receptors but the functions of these Treg cells can be modulated by some chemotherapeutic drugs like cyclophosphamide (CYP), gemcitabine, prednisolone and many more. Moreover, CYP inhibits the functions of Treg cell through various factors along with depletion of Treg cells number. Inhibition of Treg cell functions increases the activity of NK cells through modulating the expression of ARs and IRs of NK cells. Critical observation of such chemotherapeutic drugs and the regulation of NK cells on the basis of their ARs and IRs expression can be a promising chemo-immunotherapeutic approach for the treatment of cancer.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555728.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555728.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:8:y:2017:i:1:p:11-13

DOI: 10.19080/CTOIJ.2017.08.555728

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().